Advances in Diagnostics of Head and Neck Cancer: Volume II

Dear Colleagues,

The first edition of this Special Issue summarized current knowledge regarding "Advances in Diagnostics of Head and Neck Cancer". Many interesting studies have provided new and fundamental insights into the tumorigenesis and progression of head and neck cancer. Further studies on the diagnostics of head and neck cancer are required, leading to our decision to open submissions for Volume II of this Special Issue.

The relative 5-year survival rate for tumors in the head and neck area, including the oral cavity, pharynx, sinonasal cavity, and salivary glands, has increased over the last 40 years. Tobacco smoke, alcohol abuse, and viral infection with human papillomavirus are risk factors. Molecular alterations such as genetic and epigenetic aberrations in carcinogenesis of the head and neck have been identified. Head and neck cancer is a common disease and requires an interdisciplinary involvement of physicians from many specializations, including surgeons, molecular biologists, geneticists, radiotherapists, and pathologists. The main goal of this cooperation and a great deal of the research conducted around the world is to develop diagnostic methods that shorten the patient’s waiting time for treatment proposals and allow the most effective treatment method to be used. This will allow better results in the treatment of patients with head and neck tumors. The growing number of tumors in the head and neck area is the main reason for searching for new diagnostic biomarkers. Moreover, the expanded knowledge of molecular pathogenesis for head and neck cancerogenesis can be exploited to improve the diagnosis and treatment of patients with head and neck cancer.

This Special Issue aims to enrich the field of research of head and neck tumors by gathering submissions that identify diagnostic biomarkers for head and neck tumors, and that discuss new research developments in the molecular pathology of head and neck malignancies.

To contribute to the knowledge on the diagnosis of head and neck malignancies, the following topics will be considered: the molecular biology of head and neck cancer, the tumor microenvironment, and the prognostic and predictive roles of biomarkers.

Prof. Dr. Joanna Katarzyna Strzelczyk
Prof. Dr. Maciej Misiolek
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.